Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuropsychopharmacology Reports|November 2, 2022
Risk assessment of accidental falls in patients taking trazodone, quetiapine, or risperidone for insomnia: A single-center, case-control studyYoshihito Shimizu, Masatoshi Taga, Yoshimitsu Takahashi, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|January 30, 2025
Adherence to outpatient care among individuals with pre-existing psychiatric disorders following the 2024 Noto Peninsula Earthquake: A retrospective studyYusuke Nitta, Reiko Hashimoto, Yoshihito Shimizu, et al.
Chemical & Pharmaceutical Bulletin|August 4, 2020
Study of the More Suitable Drugs and Dosage Forms for Administration to Newborn Infants via Feeding Tube Using the Collection Rate as an IndicatorYoshihito Shimizu, Masatoshi Taga, Yoshimitsu Takahashi, et al.
Bioscience, Biotechnology, and Biochemistry|November 3, 2015
Elucidation of novel budding yeast separase mutantsYoshihito Shimizu, Masayoshi Nagai, Akter M S T Yeasmin, et al.
BMC Psychiatry|September 15, 2023
Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort studyMasakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, et al.
Scientific Reports|July 10, 2021
Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancerKatsunori Tozuka, Pattama Wongsirisin, Shigenori E Nagai, et al.
Asian Journal of Psychiatry|January 20, 2022
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE projectKayo Ichihashi, Yoshitaka Kyou, Naomi Hasegawa, et al.
Annals of General Psychiatry|December 25, 2022
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" projectYoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, et al.
Pageof 1